Precision Cancer Medicine
Top Stories
-
Spotlighting new research from the Momen-Heravi lab on immunotherapy response in head and neck cancer and other solid tumor types.
-
Source:
Columbia Engineering
A new study by Elham Azizi and Ben Izar shows a new technique to study cancer tissues archived in biobanks, increasing the variety of samples for analysis and the discovery of biomarkers.
-
An international team, led by cancer center researchers, has demonstrated the potential of a new, innovative approach to prostate cancer treatment.
-
Exciting new clinical investigations, including results of the ALPINE study, show promising, more effective treatment for patients with CLL.
Latest News
-
By Dr. Adam Bass
"Precision cancer medicine needs to be envisioned as understanding how cancer works, which goes far beyond individual gene mutations." Read Dr. Bass' Disruptors column for the HICCC.
-
By Gordana Vunjak-Novakovic
In our Disruptors column, Gordana Vunjak-Novakovic discusses groundbreaking work between engineers and cancer researchers to accelerate personalized therapeutics and better understand the disease.
-
By Meeri Kim
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
-
Five teams of researchers are awarded pilot grants to conduct innovative basic science, translational, and clinical research across multiple diseases.
-
In a new study by Adam Bass, MD, scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
-
Adam Bass, MD, joins the HICCC as the founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
Pages